The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Long-Acting Growth Hormone(LAGH) Market Research Report 2025
Synopsis
Highlights
The global Long-Acting Growth Hormone(LAGH) market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Long-Acting Growth Hormone(LAGH) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Long-Acting Growth Hormone(LAGH) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global manufacturers of Long-Acting Growth Hormone(LAGH) include GeneScience Pharmaceuticals, Pfizer, Novo Nordisk, Eli Lilly, Merck Serono, F. Hoffmann-La Roche, Ferring Pharmaceuticals, Ipsen and LG Life Sciences, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
The global market for Long-Acting Growth Hormone(LAGH) in Growth Hormone Deficiency (GHD) is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Powder, which accounted for % of the global market of Long-Acting Growth Hormone(LAGH) in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Long-Acting Growth Hormone(LAGH), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-Acting Growth Hormone(LAGH).
The Long-Acting Growth Hormone(LAGH) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Long-Acting Growth Hormone(LAGH) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long-Acting Growth Hormone(LAGH) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
GeneScience Pharmaceuticals
Pfizer
Novo Nordisk
Eli Lilly
Merck Serono
F. Hoffmann-La Roche
Ferring Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Anhui Anke Biotechnology
Product Type Insights
Global markets are presented by Long-Acting Growth Hormone(LAGH) type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Long-Acting Growth Hormone(LAGH) are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Long-Acting Growth Hormone(LAGH) segment by Type
Powder
Solvent
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Long-Acting Growth Hormone(LAGH) market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Long-Acting Growth Hormone(LAGH) market.
Long-Acting Growth Hormone(LAGH) segment by Application
Growth Hormone Deficiency (GHD)
Turner Syndrome
Chronic Renal Insufficiency
Prader Willi Syndrome
Small for Gestational Age(SGA)
SHOX Deficiency
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Long-Acting Growth Hormone(LAGH) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-Acting Growth Hormone(LAGH) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Long-Acting Growth Hormone(LAGH) and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Long-Acting Growth Hormone(LAGH) industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-Acting Growth Hormone(LAGH).
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Long-Acting Growth Hormone(LAGH) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Long-Acting Growth Hormone(LAGH) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
Highlights
The global Long-Acting Growth Hormone(LAGH) market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Long-Acting Growth Hormone(LAGH) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Long-Acting Growth Hormone(LAGH) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global manufacturers of Long-Acting Growth Hormone(LAGH) include GeneScience Pharmaceuticals, Pfizer, Novo Nordisk, Eli Lilly, Merck Serono, F. Hoffmann-La Roche, Ferring Pharmaceuticals, Ipsen and LG Life Sciences, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
The global market for Long-Acting Growth Hormone(LAGH) in Growth Hormone Deficiency (GHD) is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Powder, which accounted for % of the global market of Long-Acting Growth Hormone(LAGH) in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Long-Acting Growth Hormone(LAGH), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-Acting Growth Hormone(LAGH).
The Long-Acting Growth Hormone(LAGH) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Long-Acting Growth Hormone(LAGH) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long-Acting Growth Hormone(LAGH) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
GeneScience Pharmaceuticals
Pfizer
Novo Nordisk
Eli Lilly
Merck Serono
F. Hoffmann-La Roche
Ferring Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Anhui Anke Biotechnology
Product Type Insights
Global markets are presented by Long-Acting Growth Hormone(LAGH) type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Long-Acting Growth Hormone(LAGH) are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Long-Acting Growth Hormone(LAGH) segment by Type
Powder
Solvent
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Long-Acting Growth Hormone(LAGH) market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Long-Acting Growth Hormone(LAGH) market.
Long-Acting Growth Hormone(LAGH) segment by Application
Growth Hormone Deficiency (GHD)
Turner Syndrome
Chronic Renal Insufficiency
Prader Willi Syndrome
Small for Gestational Age(SGA)
SHOX Deficiency
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Long-Acting Growth Hormone(LAGH) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-Acting Growth Hormone(LAGH) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Long-Acting Growth Hormone(LAGH) and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Long-Acting Growth Hormone(LAGH) industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-Acting Growth Hormone(LAGH).
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Long-Acting Growth Hormone(LAGH) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Long-Acting Growth Hormone(LAGH) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
Index1 Long-Acting Growth Hormone(LAGH) Market Overview
1.1 Product Overview and Scope of Long-Acting Growth Hormone(LAGH)
1.2 Long-Acting Growth Hormone(LAGH) Segment by Type
1.2.1 Global Long-Acting Growth Hormone(LAGH) Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Powder
1.2.3 Solvent
1.3 Long-Acting Growth Hormone(LAGH) Segment by Application
1.3.1 Global Long-Acting Growth Hormone(LAGH) Sales Comparison by Application: (2022-2028)
1.3.2 Growth Hormone Deficiency (GHD)
1.3.3 Turner Syndrome
1.3.4 Chronic Renal Insufficiency
1.3.5 Prader Willi Syndrome
1.3.6 Small for Gestational Age(SGA)
1.3.7 SHOX Deficiency
1.3.8 Others
1.4 Global Long-Acting Growth Hormone(LAGH) Market Size Estimates and Forecasts
1.4.1 Global Long-Acting Growth Hormone(LAGH) Revenue 2017-2028
1.4.2 Global Long-Acting Growth Hormone(LAGH) Sales 2017-2028
1.4.3 Long-Acting Growth Hormone(LAGH) Market Size by Region: 2017 Versus 2021 Versus 2028
2 Long-Acting Growth Hormone(LAGH) Market Competition by Manufacturers
2.1 Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Manufacturers (2017-2022)
2.2 Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Long-Acting Growth Hormone(LAGH) Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Long-Acting Growth Hormone(LAGH) Manufacturing Sites, Area Served, Product Type
2.5 Long-Acting Growth Hormone(LAGH) Market Competitive Situation and Trends
2.5.1 Long-Acting Growth Hormone(LAGH) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Long-Acting Growth Hormone(LAGH) Players Market Share by Revenue
2.5.3 Global Long-Acting Growth Hormone(LAGH) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Long-Acting Growth Hormone(LAGH) Retrospective Market Scenario by Region
3.1 Global Long-Acting Growth Hormone(LAGH) Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Long-Acting Growth Hormone(LAGH) Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Long-Acting Growth Hormone(LAGH) Market Facts & Figures by Country
3.3.1 North America Long-Acting Growth Hormone(LAGH) Sales by Country
3.3.2 North America Long-Acting Growth Hormone(LAGH) Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Long-Acting Growth Hormone(LAGH) Market Facts & Figures by Country
3.4.1 Europe Long-Acting Growth Hormone(LAGH) Sales by Country
3.4.2 Europe Long-Acting Growth Hormone(LAGH) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Long-Acting Growth Hormone(LAGH) Market Facts & Figures by Region
3.5.1 Asia Pacific Long-Acting Growth Hormone(LAGH) Sales by Region
3.5.2 Asia Pacific Long-Acting Growth Hormone(LAGH) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Long-Acting Growth Hormone(LAGH) Market Facts & Figures by Country
3.6.1 Latin America Long-Acting Growth Hormone(LAGH) Sales by Country
3.6.2 Latin America Long-Acting Growth Hormone(LAGH) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Long-Acting Growth Hormone(LAGH) Market Facts & Figures by Country
3.7.1 Middle East and Africa Long-Acting Growth Hormone(LAGH) Sales by Country
3.7.2 Middle East and Africa Long-Acting Growth Hormone(LAGH) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Long-Acting Growth Hormone(LAGH) Historic Market Analysis by Type
4.1 Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Type (2017-2022)
4.2 Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Type (2017-2022)
4.3 Global Long-Acting Growth Hormone(LAGH) Price by Type (2017-2022)
5 Global Long-Acting Growth Hormone(LAGH) Historic Market Analysis by Application
5.1 Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Application (2017-2022)
5.2 Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Application (2017-2022)
5.3 Global Long-Acting Growth Hormone(LAGH) Price by Application (2017-2022)
6 Key Companies Profiled
6.1 GeneScience Pharmaceuticals
6.1.1 GeneScience Pharmaceuticals Corporation Information
6.1.2 GeneScience Pharmaceuticals Description and Business Overview
6.1.3 GeneScience Pharmaceuticals Long-Acting Growth Hormone(LAGH) Sales, Revenue and Gross Margin (2017-2022)
6.1.4 GeneScience Pharmaceuticals Long-Acting Growth Hormone(LAGH) Product Portfolio
6.1.5 GeneScience Pharmaceuticals Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Long-Acting Growth Hormone(LAGH) Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Pfizer Long-Acting Growth Hormone(LAGH) Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Novo Nordisk
6.3.1 Novo Nordisk Corporation Information
6.3.2 Novo Nordisk Description and Business Overview
6.3.3 Novo Nordisk Long-Acting Growth Hormone(LAGH) Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Novo Nordisk Long-Acting Growth Hormone(LAGH) Product Portfolio
6.3.5 Novo Nordisk Recent Developments/Updates
6.4 Eli Lilly
6.4.1 Eli Lilly Corporation Information
6.4.2 Eli Lilly Description and Business Overview
6.4.3 Eli Lilly Long-Acting Growth Hormone(LAGH) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Eli Lilly Long-Acting Growth Hormone(LAGH) Product Portfolio
6.4.5 Eli Lilly Recent Developments/Updates
6.5 Merck Serono
6.5.1 Merck Serono Corporation Information
6.5.2 Merck Serono Description and Business Overview
6.5.3 Merck Serono Long-Acting Growth Hormone(LAGH) Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Merck Serono Long-Acting Growth Hormone(LAGH) Product Portfolio
6.5.5 Merck Serono Recent Developments/Updates
6.6 F. Hoffmann-La Roche
6.6.1 F. Hoffmann-La Roche Corporation Information
6.6.2 F. Hoffmann-La Roche Description and Business Overview
6.6.3 F. Hoffmann-La Roche Long-Acting Growth Hormone(LAGH) Sales, Revenue and Gross Margin (2017-2022)
6.6.4 F. Hoffmann-La Roche Long-Acting Growth Hormone(LAGH) Product Portfolio
6.6.5 F. Hoffmann-La Roche Recent Developments/Updates
6.7 Ferring Pharmaceuticals
6.6.1 Ferring Pharmaceuticals Corporation Information
6.6.2 Ferring Pharmaceuticals Description and Business Overview
6.6.3 Ferring Pharmaceuticals Long-Acting Growth Hormone(LAGH) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Ferring Pharmaceuticals Long-Acting Growth Hormone(LAGH) Product Portfolio
6.7.5 Ferring Pharmaceuticals Recent Developments/Updates
6.8 Ipsen
6.8.1 Ipsen Corporation Information
6.8.2 Ipsen Description and Business Overview
6.8.3 Ipsen Long-Acting Growth Hormone(LAGH) Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Ipsen Long-Acting Growth Hormone(LAGH) Product Portfolio
6.8.5 Ipsen Recent Developments/Updates
6.9 LG Life Sciences
6.9.1 LG Life Sciences Corporation Information
6.9.2 LG Life Sciences Description and Business Overview
6.9.3 LG Life Sciences Long-Acting Growth Hormone(LAGH) Sales, Revenue and Gross Margin (2017-2022)
6.9.4 LG Life Sciences Long-Acting Growth Hormone(LAGH) Product Portfolio
6.9.5 LG Life Sciences Recent Developments/Updates
6.10 Sandoz International
6.10.1 Sandoz International Corporation Information
6.10.2 Sandoz International Description and Business Overview
6.10.3 Sandoz International Long-Acting Growth Hormone(LAGH) Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Sandoz International Long-Acting Growth Hormone(LAGH) Product Portfolio
6.10.5 Sandoz International Recent Developments/Updates
6.11 Anhui Anke Biotechnology
6.11.1 Anhui Anke Biotechnology Corporation Information
6.11.2 Anhui Anke Biotechnology Long-Acting Growth Hormone(LAGH) Description and Business Overview
6.11.3 Anhui Anke Biotechnology Long-Acting Growth Hormone(LAGH) Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Anhui Anke Biotechnology Long-Acting Growth Hormone(LAGH) Product Portfolio
6.11.5 Anhui Anke Biotechnology Recent Developments/Updates
7 Long-Acting Growth Hormone(LAGH) Manufacturing Cost Analysis
7.1 Long-Acting Growth Hormone(LAGH) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Long-Acting Growth Hormone(LAGH)
7.4 Long-Acting Growth Hormone(LAGH) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Long-Acting Growth Hormone(LAGH) Distributors List
8.3 Long-Acting Growth Hormone(LAGH) Customers
9 Long-Acting Growth Hormone(LAGH) Market Dynamics
9.1 Long-Acting Growth Hormone(LAGH) Industry Trends
9.2 Long-Acting Growth Hormone(LAGH) Market Drivers
9.3 Long-Acting Growth Hormone(LAGH) Market Challenges
9.4 Long-Acting Growth Hormone(LAGH) Market Restraints
10 Global Market Forecast
10.1 Long-Acting Growth Hormone(LAGH) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Long-Acting Growth Hormone(LAGH) by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Long-Acting Growth Hormone(LAGH) by Type (2023-2028)
10.2 Long-Acting Growth Hormone(LAGH) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Long-Acting Growth Hormone(LAGH) by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Long-Acting Growth Hormone(LAGH) by Application (2023-2028)
10.3 Long-Acting Growth Hormone(LAGH) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Long-Acting Growth Hormone(LAGH) by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Long-Acting Growth Hormone(LAGH) by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Long-Acting Growth Hormone(LAGH) Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Long-Acting Growth Hormone(LAGH) Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Long-Acting Growth Hormone(LAGH) Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Long-Acting Growth Hormone(LAGH) Market Competitive Situation by Manufacturers in 2021
Table 5. Global Long-Acting Growth Hormone(LAGH) Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Long-Acting Growth Hormone(LAGH) Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Long-Acting Growth Hormone(LAGH) Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Long-Acting Growth Hormone(LAGH) Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Long-Acting Growth Hormone(LAGH) Manufacturing Sites and Area Served
Table 11. Manufacturers Long-Acting Growth Hormone(LAGH) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Long-Acting Growth Hormone(LAGH) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long-Acting Growth Hormone(LAGH) as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Long-Acting Growth Hormone(LAGH) Sales by Region (2017-2022) & (K Units)
Table 16. Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Region (2017-2022)
Table 17. Global Long-Acting Growth Hormone(LAGH) Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Region (2017-2022)
Table 19. North America Long-Acting Growth Hormone(LAGH) Sales by Country (2017-2022) & (K Units)
Table 20. North America Long-Acting Growth Hormone(LAGH) Sales Market Share by Country (2017-2022)
Table 21. North America Long-Acting Growth Hormone(LAGH) Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Long-Acting Growth Hormone(LAGH) Revenue Market Share by Country (2017-2022)
Table 23. Europe Long-Acting Growth Hormone(LAGH) Sales by Country (2017-2022) & (K Units)
Table 24. Europe Long-Acting Growth Hormone(LAGH) Sales Market Share by Country (2017-2022)
Table 25. Europe Long-Acting Growth Hormone(LAGH) Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Long-Acting Growth Hormone(LAGH) Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Long-Acting Growth Hormone(LAGH) Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Long-Acting Growth Hormone(LAGH) Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Long-Acting Growth Hormone(LAGH) Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Long-Acting Growth Hormone(LAGH) Revenue Market Share by Region (2017-2022)
Table 31. Latin America Long-Acting Growth Hormone(LAGH) Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Long-Acting Growth Hormone(LAGH) Sales Market Share by Country (2017-2022)
Table 33. Latin America Long-Acting Growth Hormone(LAGH) Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Long-Acting Growth Hormone(LAGH) Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Long-Acting Growth Hormone(LAGH) Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Long-Acting Growth Hormone(LAGH) Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Long-Acting Growth Hormone(LAGH) Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Long-Acting Growth Hormone(LAGH) Revenue Market Share by Country (2017-2022)
Table 39. Global Long-Acting Growth Hormone(LAGH) Sales by Type (2017-2022) & (K Units)
Table 40. Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Type (2017-2022)
Table 41. Global Long-Acting Growth Hormone(LAGH) Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Long-Acting Growth Hormone(LAGH) Revenue Share by Type (2017-2022)
Table 43. Global Long-Acting Growth Hormone(LAGH) Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Long-Acting Growth Hormone(LAGH) Sales (K Units) by Application (2017-2022)
Table 45. Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Application (2017-2022)
Table 46. Global Long-Acting Growth Hormone(LAGH) Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Long-Acting Growth Hormone(LAGH) Revenue Share by Application (2017-2022)
Table 48. Global Long-Acting Growth Hormone(LAGH) Price by Application (2017-2022) & (US$/Unit)
Table 49. GeneScience Pharmaceuticals Corporation Information
Table 50. GeneScience Pharmaceuticals Description and Business Overview
Table 51. GeneScience Pharmaceuticals Long-Acting Growth Hormone(LAGH) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. GeneScience Pharmaceuticals Long-Acting Growth Hormone(LAGH) Product
Table 53. GeneScience Pharmaceuticals Recent Developments/Updates
Table 54. Pfizer Corporation Information
Table 55. Pfizer Description and Business Overview
Table 56. Pfizer Long-Acting Growth Hormone(LAGH) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Pfizer Long-Acting Growth Hormone(LAGH) Product
Table 58. Pfizer Recent Developments/Updates
Table 59. Novo Nordisk Corporation Information
Table 60. Novo Nordisk Description and Business Overview
Table 61. Novo Nordisk Long-Acting Growth Hormone(LAGH) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Novo Nordisk Long-Acting Growth Hormone(LAGH) Product
Table 63. Novo Nordisk Recent Developments/Updates
Table 64. Eli Lilly Corporation Information
Table 65. Eli Lilly Description and Business Overview
Table 66. Eli Lilly Long-Acting Growth Hormone(LAGH) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Eli Lilly Long-Acting Growth Hormone(LAGH) Product
Table 68. Eli Lilly Recent Developments/Updates
Table 69. Merck Serono Corporation Information
Table 70. Merck Serono Description and Business Overview
Table 71. Merck Serono Long-Acting Growth Hormone(LAGH) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Merck Serono Long-Acting Growth Hormone(LAGH) Product
Table 73. Merck Serono Recent Developments/Updates
Table 74. F. Hoffmann-La Roche Corporation Information
Table 75. F. Hoffmann-La Roche Description and Business Overview
Table 76. F. Hoffmann-La Roche Long-Acting Growth Hormone(LAGH) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. F. Hoffmann-La Roche Long-Acting Growth Hormone(LAGH) Product
Table 78. F. Hoffmann-La Roche Recent Developments/Updates
Table 79. Ferring Pharmaceuticals Corporation Information
Table 80. Ferring Pharmaceuticals Description and Business Overview
Table 81. Ferring Pharmaceuticals Long-Acting Growth Hormone(LAGH) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Ferring Pharmaceuticals Long-Acting Growth Hormone(LAGH) Product
Table 83. Ferring Pharmaceuticals Recent Developments/Updates
Table 84. Ipsen Corporation Information
Table 85. Ipsen Description and Business Overview
Table 86. Ipsen Long-Acting Growth Hormone(LAGH) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Ipsen Long-Acting Growth Hormone(LAGH) Product
Table 88. Ipsen Recent Developments/Updates
Table 89. LG Life Sciences Corporation Information
Table 90. LG Life Sciences Description and Business Overview
Table 91. LG Life Sciences Long-Acting Growth Hormone(LAGH) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. LG Life Sciences Long-Acting Growth Hormone(LAGH) Product
Table 93. LG Life Sciences Recent Developments/Updates
Table 94. Sandoz International Corporation Information
Table 95. Sandoz International Description and Business Overview
Table 96. Sandoz International Long-Acting Growth Hormone(LAGH) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Sandoz International Long-Acting Growth Hormone(LAGH) Product
Table 98. Sandoz International Recent Developments/Updates
Table 99. Anhui Anke Biotechnology Corporation Information
Table 100. Anhui Anke Biotechnology Description and Business Overview
Table 101. Anhui Anke Biotechnology Long-Acting Growth Hormone(LAGH) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Anhui Anke Biotechnology Long-Acting Growth Hormone(LAGH) Product
Table 103. Anhui Anke Biotechnology Recent Developments/Updates
Table 104. Production Base and Market Concentration Rate of Raw Material
Table 105. Key Suppliers of Raw Materials
Table 106. Long-Acting Growth Hormone(LAGH) Distributors List
Table 107. Long-Acting Growth Hormone(LAGH) Customers List
Table 108. Long-Acting Growth Hormone(LAGH) Market Trends
Table 109. Long-Acting Growth Hormone(LAGH) Market Drivers
Table 110. Long-Acting Growth Hormone(LAGH) Market Challenges
Table 111. Long-Acting Growth Hormone(LAGH) Market Restraints
Table 112. Global Long-Acting Growth Hormone(LAGH) Sales Forecast by Type (2023-2028) & (K Units)
Table 113. Global Long-Acting Growth Hormone(LAGH) Sales Market Share Forecast by Type (2023-2028)
Table 114. Global Long-Acting Growth Hormone(LAGH) Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 115. Global Long-Acting Growth Hormone(LAGH) Revenue Market Share Forecast by Type (2023-2028)
Table 116. Global Long-Acting Growth Hormone(LAGH) Sales Forecast by Application (2023-2028) & (K Units)
Table 117. Global Long-Acting Growth Hormone(LAGH) Sales Market Share Forecast by Application (2023-2028)
Table 118. Global Long-Acting Growth Hormone(LAGH) Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 119. Global Long-Acting Growth Hormone(LAGH) Revenue Market Share Forecast by Application (2023-2028)
Table 120. Global Long-Acting Growth Hormone(LAGH) Sales Forecast by Region (2023-2028) & (K Units)
Table 121. Global Long-Acting Growth Hormone(LAGH) Sales Market Share Forecast by Region (2023-2028)
Table 122. Global Long-Acting Growth Hormone(LAGH) Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 123. Global Long-Acting Growth Hormone(LAGH) Revenue Market Share Forecast by Region (2023-2028)
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Long-Acting Growth Hormone(LAGH)
Figure 2. Global Long-Acting Growth Hormone(LAGH) Market Share by Type in 2021 & 2028
Figure 3. Powder Product Picture
Figure 4. Solvent Product Picture
Figure 5. Global Long-Acting Growth Hormone(LAGH) Market Share by Application in 2021 & 2028
Figure 6. Growth Hormone Deficiency (GHD)
Figure 7. Turner Syndrome
Figure 8. Chronic Renal Insufficiency
Figure 9. Prader Willi Syndrome
Figure 10. Small for Gestational Age(SGA)
Figure 11. SHOX Deficiency
Figure 12. Others
Figure 13. Global Long-Acting Growth Hormone(LAGH) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Long-Acting Growth Hormone(LAGH) Market Size (2017-2028) & (US$ Million)
Figure 15. Global Long-Acting Growth Hormone(LAGH) Sales (2017-2028) & (K Units)
Figure 16. Long-Acting Growth Hormone(LAGH) Sales Share by Manufacturers in 2021
Figure 17. Global Long-Acting Growth Hormone(LAGH) Revenue Share by Manufacturers in 2021
Figure 18. The Global 5 and 10 Largest Long-Acting Growth Hormone(LAGH) Players: Market Share by Revenue in 2021
Figure 19. Long-Acting Growth Hormone(LAGH) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 20. Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Region (2017-2022)
Figure 21. Global Long-Acting Growth Hormone(LAGH) Sales Market Share by Region in 2021
Figure 22. Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Region (2017-2022)
Figure 23. Global Long-Acting Growth Hormone(LAGH) Revenue Market Share by Region in 2021
Figure 24. United States Long-Acting Growth Hormone(LAGH) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Canada Long-Acting Growth Hormone(LAGH) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Germany Long-Acting Growth Hormone(LAGH) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. France Long-Acting Growth Hormone(LAGH) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. U.K. Long-Acting Growth Hormone(LAGH) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Italy Long-Acting Growth Hormone(LAGH) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Russia Long-Acting Growth Hormone(LAGH) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Long-Acting Growth Hormone(LAGH) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Japan Long-Acting Growth Hormone(LAGH) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. South Korea Long-Acting Growth Hormone(LAGH) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. India Long-Acting Growth Hormone(LAGH) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Australia Long-Acting Growth Hormone(LAGH) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. China Taiwan Long-Acting Growth Hormone(LAGH) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Indonesia Long-Acting Growth Hormone(LAGH) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Thailand Long-Acting Growth Hormone(LAGH) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Malaysia Long-Acting Growth Hormone(LAGH) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Mexico Long-Acting Growth Hormone(LAGH) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Brazil Long-Acting Growth Hormone(LAGH) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Argentina Long-Acting Growth Hormone(LAGH) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Turkey Long-Acting Growth Hormone(LAGH) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Saudi Arabia Long-Acting Growth Hormone(LAGH) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. UAE Long-Acting Growth Hormone(LAGH) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Sales Market Share of Long-Acting Growth Hormone(LAGH) by Type (2017-2022)
Figure 47. Manufacturing Cost Structure of Long-Acting Growth Hormone(LAGH)
Figure 48. Manufacturing Process Analysis of Long-Acting Growth Hormone(LAGH)
Figure 49. Long-Acting Growth Hormone(LAGH) Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
